Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

VRTX | Vertex Pharmaceuticals, Inc.

Index	NDX, S&P 500	P/E	27.11	EPS (ttm)	12.94	Insider Own	0.36%	Shs Outstand	258.10M	Perf Week	-0.38%
Market Cap	90.51B	Forward P/E	21.91	EPS next Y	16.00	Insider Trans	-11.74%	Shs Float	257.18M	Perf Month	1.12%
Income	3.36B	PEG	2.73	EPS next Q	3.93	Inst Own	93.42%	Short Float / Ratio	1.14% / 2.87	Perf Quarter	0.93%
Sales	9.36B	P/S	9.67	EPS this Y	-1.70%	Inst Trans	1.20%	Short Interest	2.92M	Perf Half Y	11.54%
Book/sh	60.01	P/B	5.84	EPS next Y	9.41%	ROA	18.73%	Target Price	386.81	Perf Year	22.47%
Cash/sh	43.54	P/C	8.05	EPS next 5Y	9.93%	ROE	24.56%	52W Range	276.57 - 367.00	Perf YTD	21.43%
Dividend	-	P/FCF	23.33	EPS past 5Y	65.26%	ROI	20.72%	52W High	-4.45%	Beta	0.50
Dividend %	-	Quick Ratio	3.96	Sales past 5Y	29.17%	Gross Margin	87.73%	52W Low	26.79%	ATR	5.67
Employees	4800	Current Ratio	4.14	Sales Q/Q	15.52%	Oper. Margin	41.05%	RSI (14)	51.42	Volatility	1.90% 1.49%
Optionable	Yes	Debt/Eq	0.05	EPS Q/Q	12.24%	Profit Margin	35.96%	Rel Volume	0.69	Prev Close	349.53
Shortable	Yes	LT Debt/Eq	0.05	Earnings	Aug 01 AMC	Payout	0.00%	Avg Volume	1.02M	Price	350.67
Recom	1.78	SMA20	0.36%	SMA50	0.08%	SMA200	7.59%	Volume	697,946	Change	0.33%

Date	Action	Analyst	Rating Change	Price Target Change
May-30-23	Initiated	William Blair	Outperform	$382
May-04-23	Resumed	Piper Sandler	Overweight	$385
Mar-21-23	Initiated	Bernstein	Outperform	$344
Jan-18-23	Initiated	Canaccord Genuity	Hold	$311
Jan-17-23	Upgrade	SVB Leerink	Mkt Perform → Outperform	$374
Dec-19-22	Downgrade	Jefferies	Buy → Hold	$340
Jul-13-22	Initiated	Cantor Fitzgerald	Overweight	$365
Jun-01-22	Upgrade	Maxim Group	Hold → Buy	$325
May-23-22	Initiated	SVB Leerink	Mkt Perform	$265
May-06-22	Downgrade	Robert W. Baird	Outperform → Neutral	$250
May-03-22	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$250
Feb-03-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$269
Jan-27-22	Reiterated	Wolfe Research	Outperform	$271 → $282
Jan-27-22	Reiterated	Stifel	Hold	$213 → $222
Jan-27-22	Reiterated	RBC Capital Mkts	Outperform	$268 → $269
Jan-27-22	Reiterated	Morgan Stanley	Underweight	$203 → $208
Jan-27-22	Reiterated	JP Morgan	Overweight	$260 → $288
Jan-20-22	Upgrade	BMO Capital Markets	Market Perform → Outperform	$202 → $274
Dec-09-21	Initiated	Wells Fargo	Overweight	$270
Nov-19-21	Initiated	BMO Capital Markets	Market Perform	$202

Show Previous Ratings

Sep-25-23 05:50PM	Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know (Zacks)
12:22PM	Buying These 2 Remarkable Growth Stocks in Any Market Could Be a Genius Move (Motley Fool)
Sep-24-23 06:50AM	3 Magnificent Growth Stocks to Buy Right Now (Motley Fool)
Sep-23-23 08:00AM	Meta Stock Leads 5 Names Showing Resilience In Market Downturn (Investor's Business Daily)
Sep-22-23 10:07AM	2 Healthcare Stocks That Could Make You Richer (Motley Fool)
11:03PM	Loading…
Sep-21-23 11:03PM	EVP and CMO Carmen Bozic Sells 5,651 Shares of Vertex Pharmaceuticals Inc (GuruFocus.com)
05:50AM	3 Unstoppable Stocks to Buy and Hold for the Next 20 Years (Motley Fool)
Sep-20-23 08:44AM	What Makes Vertex Pharmaceuticals Incorporated (VRTX) a Unique Investment Opportunity? (Insider Monkey)
Sep-19-23 05:50PM	Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know (Zacks)
Sep-18-23 03:49PM	With ex-Vertex leader out as CEO, biotech makes layoffs, leaves Watertown HQ (American City Business Journals)
08:01AM	Vertex (VRTX) Gets Positive CHMP Opinion for Kaftrio Expanded Use (Zacks)
Sep-17-23 05:50AM	Here's the 1 Cathie Wood Stock Most Likely to Turn $100,000 Into $1 Million Over the Next 20 Years (Motley Fool)
05:30AM	Looking for Growth? These Companies' Revenue May Skyrocket (Motley Fool)
Sep-15-23 08:52AM	Vertex Receives CHMP Positive Opinion for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor for Children With Cystic Fibrosis Ages 2 Through 5 (Business Wire)
Sep-14-23 09:15AM	Vertex Researchers Awarded 2024 Breakthrough Prize in Life Sciences (Business Wire)
06:15AM	Loading…
06:15AM	Better Bull Market Buy: CRISPR vs. Medtronic Stock (Motley Fool)
05:13AM	Philanthropic disease foundations rival VCs in life sciences investments (American City Business Journals)
Sep-13-23 05:50PM	Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know (Zacks)
Sep-12-23 07:00AM	More Likely to 5x First: Bluebird Bio vs. CRISPR Therapeutics (Motley Fool)
Sep-10-23 05:52AM	A Bull Market Is (Still) Coming: Here Are 3 Spectacular Stocks to Buy Sooner Rather Than Later (Motley Fool)
Sep-09-23 06:55AM	3 Unstoppable Growth Stocks to Buy Right Now (Motley Fool)
Sep-08-23 05:07PM	EVP and CMO Carmen Bozic Sells 5,651 Shares of Vertex Pharmaceuticals Inc (GuruFocus.com)
10:15AM	1 Top Pharma Growth Stock to Buy Today and Hold Forever (Motley Fool)
09:53AM	2 Top Biotech Stocks to Buy in September (Motley Fool)
08:45AM	Could These Be Vertex Pharmaceuticals' Most Promising Candidates? (Motley Fool)
05:46AM	3 Must-Know Tricks for Investing in Big Pharma Stocks (Motley Fool)
Sep-07-23 05:50PM	Vertex Pharmaceuticals (VRTX) Stock Moves -0.1%: What You Should Know (Zacks)
06:34AM	Reshma Kewalramani aims to imbue Vertex with 'a sense of responsibility' (American City Business Journals)
Sep-05-23 06:00AM	With a Prediction for a 70% Gain, Is Wall Street Too Optimistic About This Biotech Stock? (Motley Fool)
Sep-04-23 05:06AM	5 Surefire Stocks That Can Build Generational Wealth in 20 Years (Motley Fool)
05:50AM	Loading…
Sep-03-23 05:50AM	2 Spectacular Growth Stocks You Can Buy in September With No Hesitation (Motley Fool)
Sep-01-23 05:45PM	Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know (Zacks)
11:31AM	Sarepta Therapeutics (SRPT) Up 12.7% Since Last Earnings Report: Can It Continue? (Zacks)
Aug-31-23 05:42AM	The 3 Most Promising Biotech Stocks to Own Now (InvestorPlace)
Aug-30-23 04:01PM	Vertex to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference on September 13 (Business Wire)
12:23PM	Vertex makes room in its C-suite for new technical operations role (American City Business Journals)
09:27AM	Vertex (VRTX) Outperforms Industry Year to Date: Here's Why (Zacks)
Aug-29-23 09:00AM	Vertex Appoints E. Morrey Atkinson, Ph.D., to EVP and Chief Technical Operations Officer, Head of Biopharmaceutical Sciences and Manufacturing Operations (Business Wire)
Aug-28-23 08:30AM	3 Top Growth Stocks I'd Buy Right Now Without Hesitation (Motley Fool)
Aug-24-23 04:17PM	Got $600? Here are 3 No-Brainer Stocks You Absolutely Must Buy (InvestorPlace)
07:30AM	2 No-Brainer Biotech Stocks to Buy Right Now (Motley Fool)
05:58AM	3 Clever Tricks to Find Winning Biotech Stocks (Motley Fool)
Aug-22-23 10:00AM	3 Revolutionary Stocks I'd Buy Right Now Without Hesitation (Motley Fool)
Aug-21-23 09:00AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Aug-19-23 05:06AM	4 Superlative Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip (Motley Fool)
Aug-18-23 05:50AM	3 Monster Stocks to Buy Without Any Hesitation (Motley Fool)
Aug-17-23 09:20AM	2 Excellent Stocks to Buy and Hold Forever (Motley Fool)
Aug-16-23 04:01PM	Vertex Pharmaceuticals Stock Shows Rising Relative Strength, Hits 80+ (Investor's Business Daily)
Aug-14-23 06:15AM	Missed Out on CRISPR Therapeutics? My Best Biotech Stock to Buy and Hold (Motley Fool)
Aug-13-23 05:52AM	Want to Get Richer? Buy and Hold These 5 Unstoppable Stocks (Motley Fool)
Aug-11-23 01:57PM	Meta, Google, Tesla Lead AI Stocks And More For Weekend Watchlist (Investor's Business Daily)
Aug-10-23 06:40AM	Could Vertex Pharmaceuticals Stock Help You Become a Millionaire? (Motley Fool)
05:50AM	3 Explosive Stocks to Buy Right Now (Motley Fool)
05:21AM	3 Top Biotech Stocks Defying the Bear Market (Motley Fool)
Aug-09-23 02:30PM	2 Supercharged Growth Stocks That Could Make You Richer (Motley Fool)
09:30AM	2 Great Stocks Under $100 to Buy and Hold for 10 Years (Motley Fool)
05:35AM	Is Vertex Pharmaceuticals Stock a Buy Now? (Motley Fool)
Aug-08-23 12:14PM	Why CRISPR Therapeutics Stock Is Jumping Today (Motley Fool)
11:09AM	CRISPR Therapeutics (CRSP) Q2 Loss Narrower Than Expected (Zacks)
Aug-07-23 11:01AM	CRISPR (CRSP) to Post Q2 Earnings: What's in the Offing? (Zacks)
Aug-06-23 09:15AM	2 Top Biotech Stocks to Buy in August (Motley Fool)
Aug-05-23 09:15AM	3 Top Healthcare Stocks to Buy for August (Motley Fool)
06:55AM	3 Fantastic Growth Stocks to Buy in August (Motley Fool)
Aug-04-23 09:30AM	Vertex (VRTX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
07:28AM	12 Best Biotech ETFs To Buy (Insider Monkey)
05:21AM	2 Nasdaq 100 Stocks That Are Surefire Buys in August and 1 to Avoid (Motley Fool)
Aug-03-23 09:57AM	Analyst Report: Vertex Pharmaceuticals Incorporated (Morningstar Research)
09:23AM	Company News for Aug 3, 2023 (Zacks)
08:00AM	Vertex Announces Publication of VX-548 Positive Phase 2, Proof-of-Concept Results in New England Journal of Medicine (Business Wire)
05:51AM	This Is Arguably the Single Best Stock to Buy Right Now (Motley Fool)
01:31AM	Here's Why Investors Should Buy These 2 Medical Stocks After Earnings (Zacks)
Aug-02-23 07:33PM	Vertex Pharmaceuticals (VRTX): A Fairly Valued Stock with Strong Growth Prospects (GuruFocus.com)
06:08PM	S&P 500 Gains and Losses Today: Weak Guidance from AMD Weighs on Chip Stocks (Investopedia)
04:15PM	1 No-Brainer Cathie Wood Stock to Buy Hand Over Fist in August (Motley Fool)
04:03PM	Vertex Stock Surges As Investors Eye Its Chockfull Calendar Of Expected Drug News (Investor's Business Daily)
12:50PM	Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q2 2023 Earnings Call Transcript (Insider Monkey)
12:06PM	Vertex (VRTX) Beats on Q2 Earnings & Sales, Raises '23 View (Zacks)
10:07AM	Vertex Stock Wavers Despite Chock-Full Calendar Of Expected Drug News (Investor's Business Daily)
09:16AM	Q2 2023 Vertex Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-01-23 09:00PM	Vertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcript (Motley Fool)
05:15PM	Vertex Pharmaceuticals (VRTX) Q2 Earnings and Revenues Top Estimates (Zacks)
05:15PM	Cash Machine Vertex Rides A Single Drug To Its Second-Quarter Beat And Raise (Investor's Business Daily)
04:45PM	Vertex Pharma raises full-year revenue forecast on cystic fibrosis treatment strength (Reuters)
04:15PM	Tech Leader Vertex Pharmaceuticals Beats And Raises, But Shares Inch Lower (Investor's Business Daily)
04:10PM	Vertex: Q2 Earnings Snapshot (AP Finance)
04:01PM	Vertex Reports Second Quarter 2023 Financial Results (Business Wire)
Jul-31-23 09:58AM	Drug, Biotech Stocks' Q2 Earnings Due on Aug 1: PFE, MRK & More (Zacks)
05:30AM	These 2 Stocks Are Heading for a Big Moment. Time to Buy? (Motley Fool)
Jul-27-23 12:38PM	Vertex (VRTX) to Report Q2 Earnings: What's in the Cards? (Zacks)
10:15AM	Could Vertex Pharmaceuticals Stock Help You Retire a Millionaire? (Motley Fool)
Jul-26-23 01:23PM	If You Can Only Buy One Biotech Stock, It Better Be One of These 3 Names (InvestorPlace)
11:15AM	2 No-Brainer Cathie Wood Stocks to Buy Right Now (Motley Fool)
10:02AM	Earnings Preview: Repligen (RGEN) Q2 Earnings Expected to Decline (Zacks)
Jul-25-23 05:50PM	Vertex Pharmaceuticals (VRTX) Stock Moves 0.28%: What You Should Know (Zacks)
10:01AM	Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-24-23 05:55PM	The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023 (InvestorPlace)
10:34AM	Vertex Shares Have Been Heavily Accumulated All Year (FX Empire)
Jul-22-23 05:50AM	The Best Stocks to Invest $5,000 in Right Now (Motley Fool)
Jul-21-23 08:15AM	2 Soaring Stocks With More Upside Potential (Motley Fool)
07:00AM	Vertex Pharmaceuticals (NASDAQ:VRTX) stock performs better than its underlying earnings growth over last five years (Simply Wall St.)

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bozic Carmen	EVP and CMO	Sep 19	Sale	351.00	5,651	1,983,501	51,905	Sep 21 04:15 PM
Bozic Carmen	EVP and CMO	Sep 05	Sale	352.66	5,651	1,992,882	57,556	Sep 07 04:29 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Aug 23	Sale	355.00	2,500	887,500	48,637	Aug 25 04:14 PM
Kearney Terrence C	Director	Aug 10	Option Exercise	127.54	10,000	1,275,400	16,536	Aug 14 04:09 PM
Sachdev Amit	EVP, Chief Patient Officer	Aug 10	Sale	350.00	10,031	3,510,850	58,814	Aug 14 04:05 PM
Kearney Terrence C	Director	Aug 10	Sale	350.00	10,000	3,500,000	6,536	Aug 14 04:09 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Aug 10	Sale	345.79	5,750	1,988,293	51,137	Aug 14 04:08 PM
Bhatia Sangeeta N.	Director	Aug 09	Sale	345.51	242	83,613	4,386	Aug 11 04:05 PM
ALTSHULER DAVID	EVP, Global Research and CSO	Aug 09	Sale	345.51	63	21,767	32,038	Aug 11 04:05 PM
SACHS BRUCE I	Director	Jul 17	Option Exercise	127.54	11,250	1,434,825	51,250	Jul 18 04:17 PM
SACHS BRUCE I	Director	Jul 17	Sale	356.75	11,250	4,013,459	40,000	Jul 18 04:17 PM
Kewalramani Reshma	CEO & President	Jul 17	Sale	355.00	7,828	2,778,940	118,906	Jul 18 04:13 PM
Arbuckle Stuart A	EVP, COO	Jun 15	Option Exercise	187.53	8,603	1,613,321	65,159	Jun 20 04:07 PM
Arbuckle Stuart A	EVP, COO	Jun 15	Sale	349.00	8,603	3,002,447	56,556	Jun 20 04:07 PM
Ambrose Kristen	SVP & Chief Accounting Officer	May 30	Sale	329.82	289	95,318	6,838	Jun 01 04:12 PM
Arbuckle Stuart A	EVP, COO	May 30	Sale	329.82	82	27,045	56,556	Jun 01 04:16 PM
Sanna Bastiano	EVP, Cell & Genetic Therapies	May 08	Sale	350.00	2,850	997,500	32,038	May 09 04:15 PM
LEIDEN JEFFREY M	Executive Chairman	May 08	Sale	349.00	1,125	392,625	35,387	May 09 04:10 PM
LEIDEN JEFFREY M	Executive Chairman	May 05	Sale	349.56	879	307,262	36,512	May 09 04:10 PM
Sanna Bastiano	EVP, Cell & Genetic Therapies	May 05	Sale	350.03	422	147,713	34,888	May 09 04:15 PM
LEIDEN JEFFREY M	Executive Chairman	May 03	Sale	350.11	4,508	1,578,301	37,391	May 04 04:50 PM
Sanna Bastiano	EVP, Cell & Genetic Therapies	May 03	Sale	350.74	2,781	975,418	35,310	May 04 04:51 PM
LEIDEN JEFFREY M	Executive Chairman	May 02	Sale	349.89	6,450	2,256,761	41,899	May 04 04:50 PM
Sanna Bastiano	EVP, Cell & Genetic Therapies	May 02	Sale	350.66	1,622	568,768	38,091	May 04 04:51 PM
Bhatia Sangeeta N.	Director	May 02	Sale	348.28	580	202,004	4,628	May 03 04:44 PM
Kewalramani Reshma	CEO & President	Apr 27	Sale	339.08	3,317	1,124,726	126,652	May 01 04:26 PM
SACHS BRUCE I	Director	Apr 12	Option Exercise	72.14	21,300	1,536,582	62,510	Apr 14 04:14 PM
SACHS BRUCE I	Director	Apr 12	Sale	326.73	21,300	6,959,422	41,210	Apr 14 04:14 PM
Sanna Bastiano	EVP, Cell & Genetic Therapies	Apr 12	Sale	326.70	7,567	2,472,164	39,713	Apr 14 04:19 PM
Sanna Bastiano	EVP, Cell & Genetic Therapies	Apr 04	Sale	315.81	522	164,854	47,280	Apr 06 04:23 PM
WAGNER CHARLES F JR	EVP & Chief Financial Officer	Mar 24	Sale	305.38	1,768	539,912	49,611	Mar 28 04:13 PM
WAGNER CHARLES F JR	EVP & Chief Financial Officer	Mar 17	Sale	296.39	2,000	592,786	51,379	Mar 21 04:21 PM
Sanna Bastiano	EVP, Cell & Genetic Therapies	Mar 16	Sale	300.59	2,746	825,423	49,268	Mar 20 04:26 PM
WAGNER CHARLES F JR	EVP & Chief Financial Officer	Mar 13	Sale	293.83	2,666	783,346	53,379	Mar 14 04:22 PM
WAGNER CHARLES F JR	EVP & Chief Financial Officer	Mar 10	Sale	289.61	2,088	604,709	56,045	Mar 14 04:22 PM
Arbuckle Stuart A	EVP, COO	Feb 27	Sale	287.47	5,034	1,447,143	56,556	Feb 28 04:47 PM
ALTSHULER DAVID	EVP, Global Research and CSO	Feb 27	Sale	287.51	4,238	1,218,449	32,038	Feb 28 04:40 PM
Ambrose Kristen	SVP & Chief Accounting Officer	Feb 27	Sale	287.55	1,207	347,072	7,303	Feb 28 04:44 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Feb 27	Sale	287.48	354	101,768	56,805	Feb 28 05:11 PM
Arbuckle Stuart A	EVP, COO	Feb 22	Sale	294.33	2,401	706,679	66,304	Feb 24 04:06 PM
ALTSHULER DAVID	EVP, Global Research and CSO	Feb 21	Sale	293.77	4,002	1,175,676	40,246	Feb 22 04:25 PM
Arbuckle Stuart A	EVP, COO	Feb 21	Sale	293.75	2,402	705,596	68,705	Feb 22 04:30 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Feb 21	Sale	293.75	480	141,002	60,467	Feb 22 04:48 PM
ALTSHULER DAVID	EVP, Global Research and CSO	Feb 14	Sale	298.70	6,398	1,911,108	47,998	Feb 16 04:11 PM
Arbuckle Stuart A	EVP, COO	Feb 14	Sale	298.68	6,398	1,910,962	75,605	Feb 16 04:14 PM
Sanna Bastiano	EVP, Cell & Genetic Therapies	Feb 14	Sale	300.39	2,181	655,161	59,734	Feb 16 04:16 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Feb 14	Sale	298.52	320	95,527	65,445	Feb 16 04:18 PM
Arbuckle Stuart A	EVP, COO	Feb 13	Sale	298.92	4,887	1,460,816	82,003	Feb 14 04:53 PM
ALTSHULER DAVID	EVP, Global Research and CSO	Feb 13	Sale	298.90	4,798	1,434,126	54,396	Feb 14 04:49 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Feb 13	Sale	298.99	275	82,223	65,765	Feb 14 05:12 PM
Sanna Bastiano	EVP, Cell & Genetic Therapies	Feb 13	Sale	300.39	113	33,944	61,915	Feb 14 05:08 PM
ALTSHULER DAVID	EVP, Global Research and CSO	Feb 06	Option Exercise	187.53	1,304	244,539	69,949	Feb 08 04:53 PM
ALTSHULER DAVID	EVP, Global Research and CSO	Feb 06	Sale	306.00	1,304	399,022	68,645	Feb 08 04:53 PM
SACHS BRUCE I	Director	Jan 31	Option Exercise	72.14	1,200	86,568	42,410	Feb 02 04:14 PM
SACHS BRUCE I	Director	Jan 31	Sale	325.01	1,200	390,012	41,210	Feb 02 04:14 PM
Sanna Bastiano	EVP, Cell & Genetic Therapies	Jan 31	Sale	325.00	106	34,450	37,998	Feb 02 04:18 PM
CARNEY LLOYD	Director	Jan 30	Sale	320.52	2,700	865,406	4,150	Jan 31 04:45 PM
Lee Yuchun	Director	Jan 27	Option Exercise	72.14	1,429	103,088	3,304	Jan 31 04:42 PM
Lee Yuchun	Director	Jan 27	Sale	322.03	1,429	460,177	1,875	Jan 31 04:42 PM
Lee Yuchun	Director	Jan 26	Option Exercise	72.14	4,000	288,560	5,875	Jan 27 04:18 PM
Lee Yuchun	Director	Jan 26	Sale	318.33	4,000	1,273,322	1,875	Jan 27 04:18 PM
Lee Yuchun	Director	Jan 25	Option Exercise	72.14	4,000	288,560	5,875	Jan 27 04:18 PM
Kewalramani Reshma	CEO & President	Jan 25	Sale	315.05	10,000	3,150,500	89,598	Jan 27 04:13 PM
Lee Yuchun	Director	Jan 25	Sale	313.96	4,000	1,255,852	1,875	Jan 27 04:18 PM
Lee Yuchun	Director	Jan 24	Option Exercise	72.14	4,000	288,560	5,875	Jan 25 04:08 PM
Lee Yuchun	Director	Jan 24	Sale	312.69	4,000	1,250,753	1,875	Jan 25 04:08 PM
Lee Yuchun	Director	Jan 23	Option Exercise	72.14	2,129	153,586	4,004	Jan 25 04:08 PM
Lee Yuchun	Director	Jan 23	Sale	312.02	2,129	664,291	1,875	Jan 25 04:08 PM
Lee Yuchun	Director	Jan 18	Option Exercise	72.14	442	31,886	2,317	Jan 19 04:07 PM
Lee Yuchun	Director	Jan 18	Sale	312.17	442	137,979	1,875	Jan 19 04:07 PM
Lee Yuchun	Director	Jan 17	Option Exercise	72.14	4,000	288,560	5,875	Jan 19 04:07 PM
Lee Yuchun	Director	Jan 17	Sale	312.03	4,000	1,248,120	1,875	Jan 19 04:07 PM
ALTSHULER DAVID	EVP, Global Research and CSO	Nov 15	Sale	308.61	34	10,493	36,077	Nov 17 04:08 PM
ALTSHULER DAVID	EVP, Global Research and CSO	Nov 07	Option Exercise	187.53	1,303	244,352	37,380	Nov 09 04:40 PM
ALTSHULER DAVID	EVP, Global Research and CSO	Nov 07	Sale	303.04	1,303	394,859	36,077	Nov 09 04:40 PM
Sanna Bastiano	EVP, Cell & Genetic Therapies	Nov 02	Sale	312.64	320	100,045	38,104	Nov 03 04:05 PM
Bhatia Sangeeta N.	Director	Oct 24	Sale	310.00	621	192,510	4,040	Oct 26 04:05 PM
Sanna Bastiano	EVP, Cell & Genetic Therapies	Oct 18	Sale	300.31	1,791	537,860	39,192	Oct 20 04:11 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VRTX | Vertex Pharmaceuticals, Inc.

Upgrade your FINVIZ experience